Ask the Expert: adVentures in Innovation

Commercialization Academy logo
Spark is now powered by NIH Reach
CSU Ventures logo

Ask the Expert is a collaboration between the CCTSI, Venture Partners at CU Boulder, CSU Ventures and the NIH Research Evaluation and Commercialization Hubs (REACH) grant at CU Anschutz.

The new initiative is part of CCTSI's Innovation Ecosystem program. This lunchtime series is for researchers and academics who are interested in entrepreneurship, device and technology development and innovation. Every month, academics and innovators will engage in a lively and provocative interview with an expert, followed by a Q&A session. Experts are sourced from each campus and nationally, by the Ask the Expert committee.

The series will take place on Zoom.

Richard C. Duke, PhD

Monday, August 9, 2021

Noon to 1:00 pm

Tying it all Together: Inventor, Biomedical Researcher, Executive and Serial Entrepreneur

Dr. Richard Duke will be interviewed by Dr. Cathy Bodine, Director, Innovation Ecosystems, CCTSI.

Richard C. Duke

Dr. Duke has more than 20 years of experience in building, financing and managing start-up biotechnology companies based on inventions made in Colorado’s non-profit research institutions. He is currently the Principal Investigator and Co-Director of the Research Evaluation and Commercialization Hub (REACH) at the University of Colorado Anschutz Medical Campus and the founder and Chief Scientific Officer of the Colorado Institute for Drug, Device and Diagnostic Development (CID4).

Dr. Duke is a Co-scientific founder and former CEO of GlobeImmune (NASD: GBIM) and was involved in the formation and/or management of Newellink, ApopLogic Pharmaceuticals, Sierra Neuropharmaceuticals, MenoGeniX, Aurora Oncology and AMP Discovery.

In addition to his entrepreneurial activities, Dr. Duke has more than 35 years of experience in biomedical research and is a tenured faculty member in the Department of Medicine (Medical Oncology) at the University of Colorado School of Medicine. He has provided independent 3rd party research analysis in the life sciences sector to Janus Capital and venture capital firms.

He is a graduate of McGill University (BSc and MSc) and the University of Colorado (PhD). Dr. Duke strongly believes in the merits and opportunities of building new companies based on university technologies and enjoys working with academic entrepreneurs.